ESSILORLUXOTTICA (EL.PA) › Analysis

ESSILORLUXOTTICA (EL.PA) stock analysis, January 26, 2026: Ray-Ban Meta lawsuit tests $260 support after 8.9% slide

Published January 26, 2026 · EL.PA chart, levels and live analysis

Key Updates

EssilorLuxottica declined -2.52% to $259.50 since the January 19 report, extending losses as YTD performance deteriorated to -3.85%. The stock faces mounting legal and operational headwinds: Solos Technology filed a multi-billion dollar patent infringement lawsuit targeting the Ray-Ban Meta smart glasses partnership, while production challenges persist despite Meta's consideration to double manufacturing capacity. The investment thesis remains under pressure as margin compression concerns intensify and legal uncertainties cloud the company's strategic smart glasses initiative.

Current Trend

EssilorLuxottica has entered a sustained downtrend with consecutive negative periods: -2.11% (1d), -2.52% (5d), -3.92% (1m), and -3.85% YTD. The stock has declined -8.92% from its recent peak of $284.80 on January 14, breaking below the $260 psychological support level. The 6-month performance of +3.92% indicates longer-term resilience, but near-term momentum has clearly shifted negative. Current price action suggests weakening investor confidence amid legal challenges and margin concerns, with the stock testing critical support levels established in late 2025.

Investment Thesis

The core investment thesis centers on EssilorLuxottica's dominance in the optical industry combined with strategic positioning in the emerging smart glasses market through the Meta partnership. The company operates the largest optical retail network in North America with over 1,000 LensCrafters locations and maintains leadership in prescription lenses. The Ray-Ban Meta collaboration represents a growth catalyst, with production potentially scaling to 20-30 million units annually. However, this thesis faces significant challenges: smart glasses carry gross margins of only 32% versus current 60%+ margins, potentially compressing overall margins to 58% by 2029. The Solos Technology lawsuit seeking billions in damages and an injunction creates existential risk to the smart glasses strategy, while supply constraints have forced Meta to pause international expansion, limiting near-term revenue potential.

Thesis Status

The investment thesis has materially deteriorated since the previous report. The Solos Technology patent lawsuit represents the most significant new risk, with allegations that Meta personnel reviewed Solos' technical materials and described the technology as "technically superior" before developing competing products. This legal challenge directly threatens the Ray-Ban Meta partnership's viability and could result in multi-billion dollar damages or injunctions halting sales. The margin compression concerns highlighted by RBC Capital Markets remain unresolved, while production scaling challenges persist despite demand strength. Additionally, governance uncertainty at Delfin, the controlling shareholder, adds complexity as five of eight Del Vecchio heirs push for financial asset sales, potentially creating strategic distractions.

Key Drivers

Patent Litigation Risk: Solos Technology filed a lawsuit against Meta, Oakley, Luxottica of America, and EssilorLuxottica USA seeking billions in damages and an injunction. The complaint alleges infringement of patents covering multimodal sensing, beamforming, audio processing, and intelligent assistance systems, with Solos claiming Meta personnel cited its patents as "technically superior" in internal studies. This legal battle could disrupt the Ray-Ban Meta product line and force costly settlements or design changes.

Production Scaling Challenges: Despite Meta considering doubling production capacity to 20 million units annually, the partnership faces persistent supply constraints. Meta postponed international expansion to Canada, France, the UK, and Italy due to overwhelming U.S. demand, with waitlists extending into 2026. This supply-demand imbalance limits revenue growth potential and suggests operational execution challenges.

Margin Compression: Baader Helvea downgraded EssilorLuxottica to reduce from add, cutting its price target to €282 from €319. RBC Capital Markets projects smart glasses' 32% gross margins will compress overall company margins from current 60%+ levels to 58% by 2029 as smart glasses gain market share, creating a structural headwind to profitability.

Competitive Intensity: Rokid launched AI glasses at $299, positioning as a lower-cost alternative to Ray-Ban Meta products. The expanding competitive landscape in smart glasses includes multiple entrants targeting the consumer AI wearables market, potentially limiting EssilorLuxottica's pricing power and market share.

Core Business Resilience: LensCrafters continues its marketing campaign with over 1,000 stores across North America, demonstrating the strength of EssilorLuxottica's traditional optical retail business. The company's expansion into hearing solutions with Nuance Audio provides diversification beyond vision care.

Technical Analysis

EssilorLuxottica has broken below the $260 support level at $259.50, establishing a clear downtrend with lower highs and lower lows since the January 14 peak of $284.80. The stock has declined -8.92% over 12 days, with accelerating momentum as evidenced by steepening losses: -2.11% (1d), -2.52% (5d), -3.92% (1m). The YTD performance of -3.85% indicates weakness from the start of 2026, while the 6-month gain of +3.92% suggests longer-term support exists in the $240-$250 range. Key resistance now sits at $266-$270 (previous support turned resistance), with next support at $250. Volume patterns suggest distribution as investors react to legal and operational challenges. The technical picture remains bearish unless the stock can reclaim $270 and establish higher lows.

Bull Case

Bear Case

Get a message when the EL.PA picture changes — the agent team watches the levels and the news for you.Create a free account

More EL.PA analyses